m.yildiz
TL2 Moderator · Breda
Contributes reviews on supplier material. Based in Breda.
Joined 4 April 2025 · last posted 22h
86 posts, newest first. Showing up to 150.
-
CJC-1295 with and without DAC: what the modification does Replied, post #124 · Compounds › Secretagogues & GH axis · 27 Jul 2026 · 10 likes This follows post #121 rather than contradicting it. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #25 · Analytics › Impurities & related substances · 27 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #41 · Clinical › Prescriber conversations · 24 Jul 2026 · 26 likes Worth separating two things that post #37 runs together. Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #73 · Start Here › Welcome · 23 Jul 2026 · 0 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #89 · Nutrition & Training › Protein & intake · 21 Jul 2026 · 26 likes I read post #87 twice before replying, because I had assumed the opposite. Timing of protein: spreading protein intake across the day, with some at each meal, is more…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #32 · Compounds › Semaglutide · 18 Jul 2026 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Which categories are strict and which are relaxed, honestly Replied, post #21 · Start Here › Welcome · 17 Jul 2026 · 0 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Seven-day rolling means and why weekly readings mislead Replied, post #43 · Outcomes › Progress reports · 16 Jul 2026 · 25 likes On post #39 — agreed on the reasoning, with one qualification. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #9 · Sourcing › Regulatory · 11 Jul 2026 · 8 likes Worth separating two things that post #5 runs together. Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and…
-
A site rotation scheme that is easy enough to actually follow Replied, post #110 · Practice › Administration · 9 Jul 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #30 · Evidence › Trials · 29 Jun 2026 · 9 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #21 · Practice › Dosing & titration · 27 Jun 2026 · 24 likes This follows post #18 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #46 · Compounds › Secretagogues & GH axis · 23 Jun 2026 · 3 likes Coming back to post #44, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #59 · Start Here › How to Ask · 21 Jun 2026 · 7 likes I read post #57 twice before replying, because I had assumed the opposite. Context that matters: compound, how long in, current dose, relevant history. Context that…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #11 · Analytics › Impurities & related substances · 19 Jun 2026 · 5 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #79 · Data & Tools › Datasets · 12 Jun 2026 · 17 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
What to include when your question involves a chromatogram — one year on Replied, post #31 · Start Here › How to Ask · 9 Jun 2026 · 8 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #51 · Wellbeing › Sleep · 5 Jun 2026 · 26 likes On post #47 — agreed on the reasoning, with one qualification. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #85 · Outcomes › Body composition · 29 May 2026 · 17 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
What a certificate commits its issuer to — one year on Replied, post #76 · Analytics › COA interpretation · 27 May 2026 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #30 · Analytics › Method validation · 23 May 2026 · 18 likes Worth separating two things that post #26 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #24 · Analytics › HPLC & UHPLC · 9 May 2026 · 0 likes post #23 answers the question as asked. The question underneath it is different. System suitability testing: injections run before and during the sample run to…
-
EU-wide position versus national implementation — what changed since Replied, post #25 · Regional › European Union · 1 May 2026 · 10 likes Worth separating two things that post #21 runs together. Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #123 · Clinical › Special populations · 25 Apr 2026 · 21 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #16 · Analytics › COA interpretation · 22 Apr 2026 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Follow-up: State-level differences that actually matter Replied, post #7 · Regional › North America · 3 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Five questions in one post gets you one answer — how to split them Replied, post #45 · Start Here › How to Ask · 2 Apr 2026 · 0 likes This follows post #42 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Amylin receptor signalling and satiety — what changed since Replied, post #53 · Pharmacology › Receptor biology · 30 Mar 2026 · 8 likes I read post #51 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #77 · Compounds › Cagrilintide & amylin analogues · 19 Mar 2026 · 2 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #79 · Research Methods › N-of-1 designs · 19 Mar 2026 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #64 · Lounge › Introductions · 14 Mar 2026 · 22 likes On post #60 — agreed on the reasoning, with one qualification. No spam: introductions are not a place to advertise commercial products or services. That is a rules…
-
Revisiting: Absolute versus relative contraindications Replied, post #43 · Safety › Contraindications · 14 Mar 2026 · 0 likes Coming back to post #41, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #10 · Evidence › Journal club · 7 Mar 2026 · 5 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Guidelines revision: what changed and why — one year on Replied, post #71 · Meta › Announcements · 16 Feb 2026 · 1 like Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #17 · Analytics › COA interpretation · 13 Feb 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #22 · Practice › Administration · 3 Feb 2026 · 6 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #128 · Documentation › Doc review · 8 Jan 2026 · 0 likes Picking up post #125: that is the part I would want checked first. Interdependencies: if updating one page requires updating related pages, posting that connection here…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #54 · Pharmacology › Pharmacokinetics · 7 Jan 2026 · 6 likes On post #50 — agreed on the reasoning, with one qualification. Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #66 · Compounds › Tirzepatide · 9 Dec 2025 · 18 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #9 · Meta › Site feedback · 28 Nov 2025 · 18 likes Worth separating two things that post #5 runs together. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #25 · Compounds › Tirzepatide · 27 Nov 2025 · 0 likes I read post #23 twice before replying, because I had assumed the opposite. Storage and stability: published data on licensed tirzepatide formulations exists and is…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #12 · Analytics › Impurities & related substances · 15 Nov 2025 · 0 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
[2026 update] What steady state means for the decision to escalate Replied, post #55 · Practice › Dosing & titration · 10 Nov 2025 · 0 likes Picking up post #52: that is the part I would want checked first. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #16 · Research Methods › N-of-1 designs · 2 Nov 2025 · 6 likes I read post #14 twice before replying, because I had assumed the opposite. Confounding in personal experiments: other things change when you start a medication (season,…
-
New subcategory: rationale and scope Replied, post #39 · Meta › Announcements · 16 Oct 2025 · 0 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #9 · Evidence › Journal club · 3 Oct 2025 · 6 likes I read post #7 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Sleep quality changes during weight loss — what changed since Replied, post #11 · Wellbeing › Sleep · 28 Sep 2025 · 0 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Which panel is worth repeating and which is worth ignoring Replied, post #122 · Clinical › Bloodwork · 27 Sep 2025 · 12 likes On post #118 — agreed on the reasoning, with one qualification. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free…
-
Discussing something you have already been doing Replied, post #8 · Clinical › Prescriber conversations · 23 Sep 2025 · 3 likes On post #4 — agreed on the reasoning, with one qualification. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing,…
-
Payment method and the leverage it gives you, ranked Replied, post #59 · Sourcing › Payments · 23 Sep 2025 · 16 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
What this community means by "a source", in practical terms Replied, post #99 · Start Here › Welcome · 4 Sep 2025 · 22 likes On post #95 — agreed on the reasoning, with one qualification. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #117 · Practice › Storage & stability · 19 Aug 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Cost per delivered dose, which is the number that matters Started this topic · Access › Pricing · 3 Aug 2025 · 3 likes Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #32 · Sourcing › Regulatory · 23 Jun 2025 · 10 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Sodium, potassium and magnesium when intake drops Replied, post #22 · Nutrition & Training › Hydration & electrolytes · 19 Jun 2025 · 11 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #128 · Compounds › Semaglutide · 22 May 2025 · 12 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #16 · Evidence › Journal club · 6 May 2025 · 0 likes Worth separating two things that post #12 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #6 · Evidence › Journal club · 5 May 2025 · 12 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Filing a first vendor report: a worked example Replied, post #6 · Sourcing › Vendor reports · 29 Apr 2025 · 0 likes post #5 is right about the mechanism and I think understates the practical bit. Date the report: when the analysis was done matters. Material can degrade in storage. A…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #21 · Evidence › Journal club · 24 Apr 2025 · 25 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Counter-ion content and its effect on measured mass Replied, post #23 · Analytics › Mass spectrometry · 23 Apr 2025 · 12 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
The C-cell question: rodent findings and their human context Replied, post #10 · Compounds › Semaglutide · 23 Apr 2025 · 7 likes On post #6 — agreed on the reasoning, with one qualification. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #122 · Evidence › Journal club · 22 Apr 2025 · 0 likes post #121 answers the question as asked. The question underneath it is different. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
UK access routes, dated and sourced — a second dataset Replied, post #65 · Regional › UK & Ireland · 17 Apr 2025 · 5 likes This follows post #62 rather than contradicting it. NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in…
-
A well-designed study with a badly written abstract Replied, post #21 · Evidence › Study critique · 12 Apr 2025 · 14 likes This follows post #18 rather than contradicting it. Confounding: in observational data, is there a third variable that explains the apparent association? In randomised…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #24 · Evidence › Trials · 2 Apr 2025 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. Confounding in observational data: a third variable can explain an apparent…
-
A supplier that answers analytical questions with restated claims Replied, post #34 · Sourcing › Red flags · 5 Mar 2025 · 0 likes post #33 is right about the mechanism and I think understates the practical bit. Documentation quality as a signal: a supplier that reports method identifiers,…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #18 · Sourcing › Regulatory · 28 Feb 2025 · 14 likes On post #14 — agreed on the reasoning, with one qualification. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
What changed in 2026, by region Replied, post #119 · Access › International · 3 Feb 2025 · 4 likes This follows post #116 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Scheduled maintenance and what will be unavailable Replied, post #13 · Meta › Announcements · 11 Jan 2025 · 2 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
A promotion I argued against, and why I lost Replied, post #49 · Documentation › Doc review · 3 Jan 2025 · 4 likes post #48 is right about the mechanism and I think understates the practical bit. Fact-checking: if you see a factual claim in a maintained page that you have evidence…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #44 · Practice › Interactions · 2 Jan 2025 · 0 likes I read post #42 twice before replying, because I had assumed the opposite. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #2 · Sourcing › Vendor reports · 23 Dec 2024 · 10 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Body image changing more slowly than the body Replied, post #51 · Wellbeing › Mental health · 16 Dec 2024 · 22 likes Picking up post #48: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #54 · Access › Insurance & coverage · 4 Dec 2024 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #6 · Data & Tools › Calculators · 28 Nov 2024 · 0 likes This follows post #3 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #29 · Practice › Side effects · 27 Nov 2024 · 17 likes On post #25 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #31 · Compounds › Semaglutide · 18 Nov 2024 · 7 likes Worth separating two things that post #27 runs together. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is…
-
EMA product information as a primary source — does this still hold? Replied, post #51 · Regional › European Union · 16 Nov 2024 · 2 likes Picking up post #48: that is the part I would want checked first. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for…
-
Promotion criteria, and the one that stops most nominations Replied, post #98 · Documentation › Doc review · 29 Oct 2024 · 0 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #3 · Clinical › Bloodwork · 5 Oct 2024 · 8 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #59 · Sourcing › Independent verification · 15 Sep 2024 · 21 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Identical chromatograms across two different lots Replied, post #17 · Sourcing › Red flags · 22 Aug 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Chronic kidney disease and the FLOW result Replied, post #30 · Clinical › Comorbidities · 20 Aug 2024 · 31 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Correlation in a self-tracked dataset: what it can support Replied, post #2 · Research Methods › Statistics · 19 Aug 2024 · 0 likes This follows the opening post rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #10 · Evidence › Journal club · 4 Aug 2024 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…